Business Day (Johannesburg)
26 February 2008
Africa's biggest generic drug maker, Aspen Pharmacare, cast the spotlight on the health department's battle to keep tabs on AIDS patients, as CEO Stephen Saad revealed figures yesterday suggesting one in six people enrolled on the government's free treatment programme is unaccounted for.
[ See Article ]
